News

Dr. Vinay Prasad to Head FDA Vaccine, Biologics Division
WEDNESDAY, May 7, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a ...
Fierce Biotech4d
Chutes & Ladders—Marty Makary names Vinay Prasad new CBER head
In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
FDA names outspoken Covid vaccine critic as the new vaccine chief
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...
Hindustan Times6d
Vinay Prasad, FDA’s Indian-origin vaccine pick, claimed ‘God wants Trump’ is old post
FDA Commissioner Marty Makary on Tuesday named Indian-origin hematologist oncologist Vinay Prasad as the next director of the Center for Biologics and Research FDA Commissioner Marty Makary on ...
The American Bazaar6d
FDA names Vinay Prasad as its new vaccine chief
The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...
IndiaWest6d
FDA Taps Vaxxer Skeptic Vinay Prasad To Oversee Vaccine, Gene Therapy Regulations
The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one of the agency’s most ...
The American Journal of Managed Care6d
Biotech Stocks Slide After FDA Selects Prasad to Lead CBER
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
New FDA Leadership Could Raise The Bar For Drug Approvals
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
WAVY-TV6d
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical ... FDA Commissioner Dr. Marty Makary announced the appointment Tuesday in a message to agency staff, praising ...